Moullier; Philippe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moullier; Philippe.The latest application filed is for "modified adeno-associated virus vectors and delivery thereof into the central nervous system".

Company Profile

3.5.7

Moullier; Philippe - San Sebastian ES
Moullier; Philippe - Nantes FR
Moullier, Philippe - Basse-Goulaine FR
Moullier, Philippe - Meudon FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modified adeno-associated virus vectors and delivery thereof into the central nervous system Grant 11,382,988 - Moullier , et al. July 12, 2	2022-07-12
Modified Adeno-associated Virus Vectors And Delivery Thereof Into The Central Nervous System App 20210162072 - Moullier; Philippe ; et al.	2021-06-03
Efficient Systemic Treatment Of Dystrophic Muscle Pathologies App 20200405810 - Dickson; George ; et al.	2020-12-31
Efficient systemic treatment of dystrophic muscle pathologies Grant 10,786,546 - Dickson , et al. September 29, 2	2020-09-29
Efficient Systemic Treatment Of Dystrophic Muscle Pathologies App 20190167762 - Dickson; George ; et al.	2019-06-06
Efficient systemic treatment of dystrophic muscle pathologies Grant 10,166,272 - Dickson , et al. J	2019-01-01
Efficient Systemic Treatment Of Dystrophic Muscle Pathologies App 20170157213 - Dickson; George ; et al.	2017-06-08
Inducible highly productive rAAV packaging cell-lines App 20040014031 - Salvetti, Anna ; et al.	2004-01-22
Compositions and methods for recombinant Adeno-Associated Virus production Grant 6,509,150 - Salvetti , et al. January 21, 2	2003-01-21
Biocompatible implant for the expression and in vivo secretion of a therapeutic substance App 20020098223 - Moullier, Philippe ; et al.	2002-07-25
Compositions and methods for recombinant adeno-associated virus production App 20020064878 - Salvetti, Anna ; et al.	2002-05-30
Biocompatible implant for the expression and in vivo secretion of a therapeutic substance Grant 5,906,817 - Moullier , et al. May 25, 1	1999-05-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.